LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter




The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive


The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » Medical Questions » IDSA Guidelines Flawed - Published in JCDS

 - UBBFriend: Email this page to someone!    
Author Topic: IDSA Guidelines Flawed - Published in JCDS
SandiB
LymeNet Contributor
Member # 1557

Icon 1 posted      Profile for SandiB     Send New Private Message       Edit/Delete Post   Reply With Quote 
New Evidence on Lyme Disease Supports Need for Extended Treatment
Therapy
Evidence-based article in prestigious infectious disease journal
supports ILADS treatment recommendations.

Bethesda, MD (PRWEB) June 15, 2007 -- The International Lyme and
Associated Diseases Society (ILADS) today announced that, for the first
time, evidence supporting the ILADS position on the treatment of Lyme
disease has been published in the journal Clinical Infectious Diseases
(CID), considered one of the most prestigious publications in the field
of infectious diseases and microbiology. It is the first time that
evidence supporting the ILADS position has ever been published in an
American infectious disease journal.

The duration of treatment for Lyme disease has been a contentious issue
among physicians. The fact that two major medical associations - the
Infectious Diseases Society of America (IDSA) and the International Lyme
and Associated Diseases Society (ILADS) - have released conflicting
guidelines for the diagnosis and treatment of Lyme disease has fueled
the controversy.

"Publication of our recommendations about the most effective treatment
for Lyme disease in a journal like CID is a milestone for ILADS," said
Dr. Raphael Stricker, president of ILADS. "Doctors, patients and
insurance companies need to know that the IDSA guidelines are flawed."

Difficult to Diagnose
A primary factor in the Lyme disease controversy is that the disease can
be difficult to diagnose. Not every patient suffers from the typical
"bull's-eye" rash and joint inflammation, considered classic symptoms of
Lyme disease that is transmitted by the bite of a tiny tick. ILADS
research indicates that only 50%-60% of patients typically recall a tick
bite; the rash is reported in only 35% to 60% of patients; and joint
swelling typically occurs in only 20% to 30% of patients. And given the
prevalence of over-the-counter anti-inflammatory medication such as
Ibuprofen, the joint inflammation is often masked.

Many patients with Lyme disease will continue to experience a variety of
symptoms, even after the treatment recommended by IDSA. Some of these
patients go on to develop multiple nonspecific symptoms, making it very
difficult to diagnose chronic Lyme disease.

One reason for this difficulty is that Borrelia burgdorferi, the
corkscrew-shaped bacteria that causes the disease, has an unusual
genetic makeup. This allows the bacteria to screw its way into a variety
of cells and evade the body's immune system. According to ILADS
research, the Lyme bacteria invades multiple tissues and is able to
assume a dormant state much like tuberculosis. This can make treatment
much more difficult.

Extended Therapy
Based on extensive clinical evidence, ILADS maintains that extended
antibiotic therapy for Lyme disease is sometimes necessary, particularly
in later disease that is more difficult to eradicate. Studies have shown
that Borrelia burgdorferi can persist after antibiotic treatment. In
particular, studies conducted in animals - including mice, dogs and
monkeys - indicate that the corkscrew-shaped bacteria can persist after
treatment is completed. Persistence in humans has been confirmed by
culture or molecular testing in at least a dozen studies.

"Science in this area is still evolving," according to Stricker. "We
don't have all the answers and it is too early to adopt treatment
strategies that assume we do. Meanwhile, doctors need flexible treatment
approaches," he said.

The article describing the ILADS position on treatment of Lyme disease
will be published in the July 15 issue of Clinical Infectious Diseases.

About ILADS
ILADS is a nonprofit, international, multidisciplinary medical society
dedicated to the diagnosis and appropriate treatment of Lyme disease and
associated tick-borne infections. ILADS promotes understanding of
tick-borne diseases through research and education and strongly supports
physicians and other health care professionals dedicated to advancing
the standard of care for tick-borne diseases.

For more information contact Pam Kahl at 503.284.1534.

http://www.prweb. com/releases/ 2007/6/prweb5335 64.htm

Posts: 991 | From USA | Registered: Aug 2001  |  IP: Logged | Report this post to a Moderator
Truthfinder
Frequent Contributor (1K+ posts)
Member # 8512

Icon 1 posted      Profile for Truthfinder     Send New Private Message       Edit/Delete Post   Reply With Quote 
Wow, thanks Sandi!

I'll be the IDSA is really fuming over this publication.....

This is a bit different than the mainstream media that will print whatever they are 'fed'.

Tracy

[ 18. June 2007, 06:43 AM: Message edited by: Truthfinder ]

--------------------
Tracy
.... Prayers for the Lyme Community - every day at 6 p.m. Pacific Time and 9 p.m. Eastern Time � just take a few moments to say a prayer wherever you are�.

Posts: 2966 | From Colorado | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
lou
Frequent Contributor (5K+ posts)
Member # 81

Icon 1 posted      Profile for lou     Send New Private Message       Edit/Delete Post   Reply With Quote 
This is one of the publications of the IDSA, so it is surprising that they would allow any alternative views. Would be nice to think they finally realized that suppression of any legitimate views in science is counterproductive as well as dishonest. But.....my suspicion gene is being expressed as I read this. Too good to be true?
Posts: 8430 | From Not available | Registered: Oct 2000  |  IP: Logged | Report this post to a Moderator
pigwit
LymeNet Contributor
Member # 9059

Icon 1 posted      Profile for pigwit     Send New Private Message       Edit/Delete Post   Reply With Quote 
Maybe the IDSA is trying to save face. It is described as ". . .the first time evidence supporting the ILADS position has ever been published in an American infectious disease journal".

I interpret that to mean that the IDSA has blocked publication of the evidence until now. Maybe the anti-trust investigation is starting to have some results.

The insurance companies should take notice of this apparent change of environment for the two standards of care.

Posts: 159 | From Ecuador | Registered: Apr 2006  |  IP: Logged | Report this post to a Moderator
timaca
Frequent Contributor (1K+ posts)
Member # 6911

Icon 1 posted      Profile for timaca     Send New Private Message       Edit/Delete Post   Reply With Quote 
What Journal is the JCDS?

Timaca

Posts: 2872 | From above 7,000 ft in a pine forest | Registered: Feb 2005  |  IP: Logged | Report this post to a Moderator
pineapple
LymeNet Contributor
Member # 11904

Icon 1 posted      Profile for pineapple     Send New Private Message       Edit/Delete Post   Reply With Quote 
It looks like Dr. S's article is part of a point / counterpoint.


Point: Antibiotic Therapy Is Not the Answer for Patients with Persisting Symptoms Attributable to Lyme Disease

Paul G. Auwaerter

Clinical Infectious Diseases
Volume 45(2007), pages 143 - 148
DOI: 10.1086/518854

Abstract
It is not well understood why some patients develop a subjective syndrome that includes considerable fatigue, musculoskeletal aches, and neurocognitive dysfunction after receiving standard antibiotic courses for the treatment of Lyme disease. Some practitioners use the term "chronic Lyme disease" and order prolonged courses of oral and parenteral antibiotics, believing that persistent infection with Borrelia burgdorferi is responsible.

However, well-performed prospective studies have found neither evidence of chronic infection nor a benefit worthy of long-term antibiotic therapy for these patients. Such extended antibiotic therapy poses hazards and cannot be viewed as acceptable. The term "chronic Lyme disease" should be discarded as misleading; rather, the term "postLyme disease syndrome" better reflects the postinfectious nature of this condition.

Further research is necessary to understand possible mechanisms of these chronic symptoms following Lyme disease as well as to find effective therapies.


Counterpoint: Long-Term Antibiotic Therapy Improves Persistent Symptoms Associated with Lyme Disease

Raphael B. Stricker

International Lyme and Associated Diseases Society, Bethesda, Maryland

(See the point by Auwaerter on pages 143-8)

Background. Controversy exists regarding the diagnosis and treatment of Lyme disease. Patients with persistent symptoms after standard (2-4-week) antibiotic therapy for this tickborne illness have been denied further antibiotic treatment as a result of the perception that long-term infection with the Lyme spirochete, Borrelia burgdorferi, and associated tickborne pathogens is rare or nonexistent.

Methods. I review the pathophysiology of B. burgdorferi infection and the peer-reviewed literature on diagnostic Lyme disease testing, standard treatment results, and coinfection with tickborne agents, such as Babesia, Anaplasma, Ehrlichia, and Bartonella species. I also examine uncontrolled and controlled trials of prolonged antibiotic therapy in patients with persistent symptoms of Lyme disease.

Results. The complex "stealth" pathology of B. burgdorferi allows the spirochete to invade diverse tissues, elude the immune response, and establish long-term infection. Commercial testing for Lyme disease is highly specific but relatively insensitive, especially during the later stages of disease. Numerous studies have documented the failure of standard antibiotic therapy in patients with Lyme disease. Previous uncontrolled trials and recent placebo-controlled trials suggest that prolonged antibiotic therapy (duration, >4 weeks) may be beneficial for patients with persistent Lyme disease symptoms. Tickborne coinfections may increase the severity and duration of infection with B. burgdorferi.

Conclusions. Prolonged antibiotic therapy may be useful and justifiable in patients with persistent symptoms of Lyme disease and coinfection with tickborne agents.


Received 19 February 2007; accepted 21 February 2007; electronically published 5 June 2007.
This is a modified version of a paper presented at the 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Canada, October 2006.

Clinical Infectious Diseases 2007;45:149-157
� 2007 by the Infectious Diseases Society of America. All rights reserved.

Posts: 339 | From nowhere | Registered: May 2007  |  IP: Logged | Report this post to a Moderator
Kayda
LymeNet Contributor
Member # 10565

Icon 1 posted      Profile for Kayda     Send New Private Message       Edit/Delete Post   Reply With Quote 
I was hoping to find the specific studies referenced (for both sides) that support and/or refute.

My misunderstanding was that a research paper would be published proving with evidence the necessity of long-term antibiotics.

Still, I'm glad this was published. It's not exactly what I expected.

Kayda

Posts: 582 | From midwest | Registered: Nov 2006  |  IP: Logged | Report this post to a Moderator
CaliforniaLyme
Frequent Contributor (5K+ posts)
Member # 7136

Icon 1 posted      Profile for CaliforniaLyme     Send New Private Message       Edit/Delete Post   Reply With Quote 
The first thing I thought re this was that this is to circumvent Blumenthal. To show proof they are not what they are. I hope not, but it seems awfully peculiar.

--------------------
There is no wealth but life.
-John Ruskin

All truth goes through 3 stages: first it is ridiculed: then it is violently opposed: finally it is accepted as self evident. - Schopenhauer

Posts: 5639 | From Aptos CA USA | Registered: Apr 2005  |  IP: Logged | Report this post to a Moderator
Kayda
LymeNet Contributor
Member # 10565

Icon 1 posted      Profile for Kayda     Send New Private Message       Edit/Delete Post   Reply With Quote 
Yes, peculiar. It definitely is peculiar. Is the IDSA suddenly trying to prove they are balanced and accept all view points for review?

Makes me wonder.......

Kayda

Posts: 582 | From midwest | Registered: Nov 2006  |  IP: Logged | Report this post to a Moderator
northstar
Frequent Contributor (1K+ posts)
Member # 7911

Icon 1 posted      Profile for northstar     Send New Private Message       Edit/Delete Post   Reply With Quote 
Within the last 2-3 months:

a. Forbes writes a sheer trash article.

b. American Neurologists Association (not sure if that is proper name) "adopts" IDSA guidelines.

c. This same organization starts public service announcements about abx treatment for lyme

(ok, that was stupid on their part. If they wanted it to be a public service, it would have been about tick precautions, not treatment. Sounds more like a pharmaceutical ad)

d. Forbes writes a more balanced article. Yeah, like that makes the other article go up in flames like a phoenix, and they are reborn?

e. JCID (formed by IDSA writers) writes/publishes a more balanced article (topic of this posting) .


So I think it is all public image bandaging, and in response to the ILADS momentum, media attention, and Blumenthal investigation, as pigwit suggested somewhere (cant find it).

The neurologists are now the "bad" guys.

Sort of like a shell game. But the pea is still there.

They are stupider than they appear if they think they are really fooling anyone.

Northstar

Posts: 1331 | From hither and yonder | Registered: Sep 2005  |  IP: Logged | Report this post to a Moderator
lorima
Member
Member # 11925

Icon 1 posted      Profile for lorima     Send New Private Message       Edit/Delete Post   Reply With Quote 
"It is the first time that
evidence supporting the ILADS position has ever been published in an
American infectious disease journal."

Ha! That's so ridiculous.

Anyway, it is a review article with 147 references. I just purchased access to it from the journal for $15 and printed it out, will read it later. I figure $15 is a small price to pay for such a gem.

It's copyrighted by the journal of course so I can't post it. Maybe Dr. S will find a way to make it available to us through the ILADS site soon.

Posts: 74 | From MA | Registered: May 2007  |  IP: Logged | Report this post to a Moderator
lorima
Member
Member # 11925

Icon 1 posted      Profile for lorima     Send New Private Message       Edit/Delete Post   Reply With Quote 
OOPS! I just gave IDSA $15 unnecessarily!

The article is available online at the ILADS site
http://www.ilads.org/files/publications_stricker_06_2007.pdf

Oh well, I've spent more for less.

Posts: 74 | From MA | Registered: May 2007  |  IP: Logged | Report this post to a Moderator
Kayda
LymeNet Contributor
Member # 10565

Icon 1 posted      Profile for Kayda     Send New Private Message       Edit/Delete Post   Reply With Quote 
Thanks for finding the actual article. Sorry about the $15 you spent, though.

Kayda

Posts: 582 | From midwest | Registered: Nov 2006  |  IP: Logged | Report this post to a Moderator
Soleilpie
LymeNet Contributor
Member # 8481

Icon 1 posted      Profile for Soleilpie     Send New Private Message       Edit/Delete Post   Reply With Quote 
lorima

I did the same thing! But, it was worth it for a good and important article [Smile]

Did anyone read the "Point" article before the ILADS "Counterpoint?"

I was thinking of purchasing that too, but not sure it's worth the money.

--------------------
The best index to a person's character is how he treats people who can't do him any good, and how he treats people who can't fight back.
-Abigail van Buren (Pauline Esther Friedman) (1918-2002)

Posts: 409 | From Florida | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
bettyg
Unregistered


Icon 10 posted            Edit/Delete Post   Reply With Quote 
Sandi, would you edit your post by clicking on pencil icon and put something at the top of yours that for people unable to read your post as is, see below for Bettyg's edited version for neuro lymies like herself! thank you! click edit send! reformatting this for neuro lymies like me to be able to comprehend/read this... [Big Grin]


quote:
Originally posted by SandiB:


New Evidence on Lyme Disease Supports Need for Extended Treatment Therapy Evidence-based article in prestigious infectious disease journal
supports ILADS treatment recommendations.

Bethesda, MD (PRWEB) June 15, 2007 --


The International Lyme and Associated Diseases Society (ILADS) today announced that, for the first time, evidence supporting the ILADS position on the treatment of Lyme disease has been published in the journal Clinical Infectious Diseases (CID), considered one of the most prestigious publications in the field of infectious diseases and microbiology.

It is the first time that evidence supporting the ILADS position has ever been published in an
American infectious disease journal.

The duration of treatment for Lyme disease has been a contentious issue among physicians. The fact that two major medical associations - the
Infectious Diseases Society of America (IDSA) and the International Lyme and Associated Diseases Society (ILADS) - have released conflicting
guidelines for the diagnosis and treatment of Lyme disease has fueled the controversy.

"Publication of our recommendations about the most effective treatment for Lyme disease in a journal like CID is a milestone for ILADS," said
Dr. Raphael Stricker, president of ILADS.

"Doctors, patients and insurance companies need to know that the IDSA guidelines are flawed."

Difficult to Diagnose

A primary factor in the Lyme disease controversy is that the disease can be difficult to diagnose. Not every patient suffers from the typical
"bull's-eye" rash and joint inflammation, considered classic symptoms of Lyme disease that is transmitted by the bite of a tiny tick.

ILADS research indicates that only 50%-60% of patients typically recall a tick bite;

the rash is reported in only 35% to 60% of patients; and

joint swelling typically occurs in only 20% to 30% of patients.

And given the prevalence of over-the-counter anti-inflammatory medication such as Ibuprofen, the joint inflammation is often masked.

Many patients with Lyme disease will continue to experience a variety of symptoms, even after the treatment recommended by IDSA. Some of these
patients go on to develop multiple nonspecific symptoms, making it very difficult to diagnose chronic Lyme disease.

One reason for this difficulty is that Borrelia burgdorferi, the corkscrew-shaped bacteria that causes the disease, has an unusual genetic makeup. This allows the bacteria to screw its way into a variety of cells and evade the body's immune system. According to ILADS research, the Lyme bacteria invades multiple tissues and is able to assume a dormant state much like tuberculosis. This can make treatment much more difficult.

Extended Therapy

Based on extensive clinical evidence, ILADS maintains that extended antibiotic therapy for Lyme disease is sometimes necessary, particularly
in later disease that is more difficult to eradicate. Studies have shown that Borrelia burgdorferi can persist after antibiotic treatment.

In particular, studies conducted in animals - including mice, dogs and monkeys - indicate that the corkscrew-shaped bacteria can persist after
treatment is completed. Persistence in humans has been confirmed by culture or molecular testing in at least a dozen studies.

"Science in this area is still evolving," according to Stricker. "We don't have all the answers and it is too early to adopt treatment
strategies that assume we do. Meanwhile, doctors need flexible treatment approaches," he said.

The article describing the ILADS position on treatment of Lyme disease will be published in the July 15 issue of Clinical Infectious Diseases .

About ILADS

ILADS is a nonprofit, international, multidisciplinary medical society dedicated to the diagnosis and appropriate treatment of Lyme disease and associated tick-borne infections.

ILADS promotes understanding of tick-borne diseases through research and education and strongly supports physicians and other health care professionals dedicated to advancing the standard of care for tick-borne diseases.

For more information contact Pam Kahl at 503.284.1534.

http://www.prweb. com/releases/ 2007/6/prweb5335 64.htm


IP: Logged | Report this post to a Moderator
Areneli
Frequent Contributor (1K+ posts)
Member # 6740

Icon 1 posted      Profile for Areneli     Send New Private Message       Edit/Delete Post   Reply With Quote 
We may never have a proof but to my eye this ILADS article published in IDSA controlled journal must be a result of under the table agreement between Blumenthal and IDSA.
Blumenthal didn't want to lay formal charges (this would be an uncomfortable precedent) but instead pushed IDSA to publish the opposite view within their own domain.
In this way the offenders go unpunished but the harm is somehow reversed.


I am really surprised that LDA did nothing (or very little) to propagate this article in the media.

Do we need some better leadership?

Posts: 1538 | From Planet Earth | Registered: Jan 2005  |  IP: Logged | Report this post to a Moderator
Michelle M
Frequent Contributor (1K+ posts)
Member # 7200

Icon 1 posted      Profile for Michelle M   Author's Homepage     Send New Private Message       Edit/Delete Post   Reply With Quote 
quote:
Originally posted by northstar:

They are stupider than they appear if they think they are really fooling anyone.

Northstar

This would be extremely dificult, if not outright impossible.

Michelle


[toilet]

Posts: 3193 | From Northern California | Registered: Apr 2005  |  IP: Logged | Report this post to a Moderator
MarsyNY
LymeNet Contributor
Member # 7766

Icon 1 posted      Profile for MarsyNY     Send New Private Message       Edit/Delete Post   Reply With Quote 
"This allows the bacteria to screw its way into a variety of cells" another lovely image planted into our brains. Who wrote that?

No mention of the fact that lyme may be harder to eradicate in some people because of the presence of co-infectons. All patients who need extended antibiotic treatment should be tested for other tickborne infections as well or something like that would have been nice. Cant push it I guess.

Posts: 465 | From New York, NY | Registered: Aug 2005  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code� is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3


The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA


| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.